Pharmacological interventions for paranoid personality disorder

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Paranoid personality disorder (PPD) is characterized by pervasive distrust and suspicion.
• Limited evidence exists on effective pharmacological interventions for PPD.

Purpose of the Study:

• To systematically evaluate the efficacy of pharmacological interventions for individuals diagnosed with paranoid personality disorder (PPD).

Main Methods:

• This is a protocol for a systematic review.
• The review will synthesize evidence from randomized controlled trials and other relevant studies.
• Data will be extracted on intervention type, dosage, duration, and outcomes.

Main Results:

• Results are pending completion of the systematic review.
• The review will identify which pharmacological agents, if any, demonstrate efficacy in treating PPD.

Conclusions:

• Conclusions will be drawn upon synthesis of the evidence.
• Findings will inform clinical practice guidelines for PPD pharmacotherapy.